|
US5389632A
(en)
|
1992-02-24 |
1995-02-14 |
Laboratoires Upsa |
Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
|
|
EP0714898B1
(en)
*
|
1994-06-21 |
2001-11-14 |
Otsuka Pharmaceutical Factory, Inc. |
PYRAZOLO [1,5-a]PYRIMIDINE DERIVATIVE
|
|
AU747708B2
(en)
|
1996-07-24 |
2002-05-23 |
Du Pont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
|
US20010007867A1
(en)
|
1999-12-13 |
2001-07-12 |
Yuhpyng L. Chen |
Substituted 6,5-hetero-bicyclic derivatives
|
|
YU23602A
(sh)
|
1999-09-30 |
2004-09-03 |
Neurogen Corporation |
Amino supstituisani pirazolo /1,5/a/-1,5-pirimidini i pirazolo /1,5-a/-1,3,5-triazini
|
|
PL354675A1
(en)
|
1999-09-30 |
2004-02-09 |
Neurogen Corporation |
Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
|
JP2002308879A
(ja)
|
2001-04-13 |
2002-10-23 |
Nippon Soda Co Ltd |
5−ハロアルキル−アゾロピリミジン化合物、製造方法及び有害生物防除剤
|
|
CA2483306A1
(en)
|
2002-04-23 |
2003-11-06 |
Shionogi & Co., Ltd. |
Pyrazolo[1,5-a]pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
|
|
WO2003095455A2
(en)
|
2002-05-10 |
2003-11-20 |
Smithkline Beecham Corporation |
Substituted pyrazolopyrimidines
|
|
WO2003101993A1
(en)
|
2002-06-04 |
2003-12-11 |
Neogenesis Pharmaceuticals, Inc. |
Pyrazolo` 1,5a! pyrimidine compounds as antiviral agents
|
|
US7563798B2
(en)
|
2002-09-04 |
2009-07-21 |
Schering Corporation |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
|
US7605155B2
(en)
*
|
2002-09-04 |
2009-10-20 |
Schering Corporation |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
|
DE60313872T2
(de)
*
|
2002-09-04 |
2008-01-17 |
Schering Corp. |
Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
|
|
US7205308B2
(en)
|
2002-09-04 |
2007-04-17 |
Schering Corporation |
Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US8580782B2
(en)
|
2002-09-04 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
|
US7119200B2
(en)
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US7196078B2
(en)
*
|
2002-09-04 |
2007-03-27 |
Schering Corpoartion |
Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
JP4881558B2
(ja)
*
|
2002-09-04 |
2012-02-22 |
シェーリング コーポレイション |
サイクリン依存性キナーゼインヒビターとしてのピラゾロピリミジン
|
|
US7161003B1
(en)
|
2002-09-04 |
2007-01-09 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
GB0305559D0
(en)
|
2003-03-11 |
2003-04-16 |
Teijin Ltd |
Compounds
|
|
WO2004087707A1
(en)
|
2003-03-31 |
2004-10-14 |
Vernalis (Cambridge) Limited |
Pyrazolopyrimidine compounds and their use in medicine
|
|
EP1615697A2
(en)
|
2003-04-11 |
2006-01-18 |
Novo Nordisk A/S |
New pyrazolo[1,5-a] pyrimidine derivatives and pharmaceutical use thereof
|
|
US7501405B2
(en)
|
2003-04-11 |
2009-03-10 |
High Point Pharmaceuticals, Llc |
Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders
|
|
JP2005008581A
(ja)
|
2003-06-20 |
2005-01-13 |
Kissei Pharmaceut Co Ltd |
新規なピラゾロ[1,5−a]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
|
|
EP1671962A1
(en)
|
2003-10-10 |
2006-06-21 |
Ono Pharmaceutical Co., Ltd. |
Novel fused heterocyclic compound and use thereof
|
|
US20070293511A1
(en)
|
2003-12-22 |
2007-12-20 |
Sb Pharmco Puerto Rico Inc. And Neurocrine Biosciences, Inc., A Corporation |
Crf Receptor Antagonists and Methods
|
|
US8018479B2
(en)
|
2008-08-27 |
2011-09-13 |
Lexmark International, Inc. |
Method and system for correcting the linearity error in electrophotographic devices
|
|
CA2576949A1
(en)
*
|
2004-08-13 |
2006-02-16 |
Teijin Pharma Limited |
Pyrazolo[1,5-a]pyrimidine derivatives
|
|
CN101119998A
(zh)
|
2004-12-21 |
2008-02-06 |
先灵公司 |
吡唑并[1,5-A]嘧啶腺苷A2a受体拮抗剂
|
|
DE102005007534A1
(de)
|
2005-02-17 |
2006-08-31 |
Bayer Cropscience Ag |
Pyrazolopyrimidine
|
|
EP1931675B1
(en)
|
2005-10-06 |
2015-01-14 |
Merck Sharp & Dohme Corp. |
Pyrazolo(1, 5a) pyrimidines as protein kinase inhibitors
|
|
US20070082900A1
(en)
*
|
2005-10-06 |
2007-04-12 |
Schering Corporation |
Methods for inhibiting protein kinases
|
|
US8188097B2
(en)
|
2005-10-21 |
2012-05-29 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazolo[1,5-A]pyrimidine compounds
|
|
US7908091B2
(en)
|
2006-03-17 |
2011-03-15 |
Prometheus Laboratories Inc. |
Methods of predicting and monitoring tyrosine kinase inhibitor therapy
|
|
EP2027127A1
(en)
|
2006-05-22 |
2009-02-25 |
Shering Corporation |
Pyrazolo [1, 5-a]pyrimidines as cdk inhibitors
|
|
JP2010529140A
(ja)
|
2007-06-05 |
2010-08-26 |
エモリー・ユニバーシテイ |
サイクリン依存性キナーゼの選択的阻害剤
|
|
CA2691932A1
(en)
|
2007-06-27 |
2008-12-31 |
Summit Corporation Plc |
Use of compounds for preparing anti-tuberculosis agents
|
|
CA2728559A1
(en)
|
2008-07-03 |
2010-01-07 |
Exelixis Inc. |
Cdk modulators
|
|
WO2010074284A1
(ja)
|
2008-12-26 |
2010-07-01 |
味の素株式会社 |
ピラゾロピリミジン化合物
|
|
US8993612B2
(en)
|
2009-10-08 |
2015-03-31 |
Rhizen Pharmaceuticals Sa |
Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
|
|
PL2509602T3
(pl)
|
2009-12-04 |
2017-08-31 |
Senhwa Biosciences, Inc. |
Pirazolopirymidyny i podobne heterocykle jako inhibitory ck2
|
|
PH12012501643A1
(en)
|
2010-02-26 |
2017-07-19 |
Mitsubishi Tanabe Pharma Corp |
Pyrazolopyrimidine compounds and their use as pde 10 inhibitors
|
|
WO2011108689A1
(ja)
|
2010-03-05 |
2011-09-09 |
協和発酵キリン株式会社 |
ピラゾロピリミジン誘導体
|
|
CN102958933B
(zh)
|
2010-06-24 |
2016-02-03 |
吉里德科学公司 |
作为抗病毒药的吡唑并[1,5-a]嘧啶类
|
|
JP5985473B2
(ja)
|
2010-07-13 |
2016-09-06 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
IRAK4モジュレーターとしてのピラゾロ[1,5a]ピリミジン及びチエノ[3,2b]ピリミジン誘導体
|
|
US8883801B2
(en)
|
2010-08-23 |
2014-11-11 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
|
|
WO2012044562A2
(en)
|
2010-09-30 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Pyrazolopyrimidine pde10 inhibitors
|
|
WO2012170827A2
(en)
|
2011-06-08 |
2012-12-13 |
Cylene Pharmaceuticals, Inc. |
Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
|
|
EP2802588B1
(en)
|
2012-01-10 |
2016-05-25 |
Bayer Intellectual Property GmbH |
Substituted pyrazolopyrimidines as akt kinase inhibitors
|
|
UA116534C2
(uk)
|
2012-02-17 |
2018-04-10 |
Мілленніум Фармасьютікалз, Інк. |
Піразолопіримідинілові інгібітори убіквітинактивуючого ферменту
|
|
WO2013130943A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Alkyl-and di-substituted amido-benzyl sulfonamide derivatives
|
|
EP2920181B1
(en)
|
2012-11-16 |
2019-01-09 |
University Health Network |
Pyrazolopyrimidine compounds
|
|
MX2015011678A
(es)
|
2013-03-14 |
2016-07-08 |
Celtaxsys Inc |
Inhibidores de leucotrieno a4 hidrolasa.
|
|
SG11201507629XA
(en)
*
|
2013-03-15 |
2015-10-29 |
Human Biomolecular Res Inst |
Compounds and matrices for use in bone growth and repair
|
|
GB201403093D0
(en)
*
|
2014-02-21 |
2014-04-09 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
WO2015153732A2
(en)
|
2014-04-01 |
2015-10-08 |
Cornell University |
Use of double-stranded dna in exosomes: a novel biomarker in cancer detection
|
|
EP3805218A1
(en)
|
2014-04-05 |
2021-04-14 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
EP3268000B1
(en)
|
2015-03-09 |
2021-08-04 |
Aurigene Discovery Technologies Limited |
Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
|
|
CN107427521B
(zh)
|
2015-03-27 |
2021-08-03 |
达纳-法伯癌症研究所股份有限公司 |
细胞周期蛋白依赖性激酶的抑制剂
|
|
WO2016169995A1
(en)
|
2015-04-20 |
2016-10-27 |
AbbVie Deutschland GmbH & Co. KG |
Substituted pyrazolopyrimidines and method of use
|
|
CA2986441A1
(en)
|
2015-06-12 |
2016-12-15 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
ES2767776T3
(es)
|
2015-10-01 |
2020-06-18 |
Bristol Myers Squibb Co |
Inhibidores de biaril cinasa
|
|
JP2018199623A
(ja)
|
2015-10-22 |
2018-12-20 |
大正製薬株式会社 |
含窒素縮合複素環化合物
|
|
SG10201912607SA
(en)
|
2015-11-19 |
2020-02-27 |
Blueprint Medicines Corp |
Compounds and compositions useful for treating disorders related to ntrk
|
|
WO2017180499A2
(en)
|
2016-04-13 |
2017-10-19 |
President And Fellows Of Harvard College |
Methods for capturing, isolation, and targeting of circulating tumor cells and diagnostic and therapeutic applications thereof
|
|
WO2019023654A2
(en)
*
|
2017-07-28 |
2019-01-31 |
Massachusetts Institute Of Technology |
DISCOVERING SMALL MOLECULES TARGETING THE ANDROGEN RECEPTOR AND USES THEREOF
|
|
IL317854A
(en)
|
2017-07-28 |
2025-02-01 |
Takeda Pharmaceuticals Co |
TYK2 inhibitors and their uses
|
|
KR20250174699A
(ko)
*
|
2018-10-30 |
2025-12-12 |
크로노스 바이오, 인코포레이티드 |
Cdk9 활성을 조절하기 위한 화합물, 조성물 및 방법
|